Sanofi said it will invest at least $20 billion in the US through 2030, joining other pharmaceutical companies boosting their American operations as President Donald Trump threatens to impose tariffs and cut prices on drugs.
The investments will include a “significant increase” in research and development spending and billions of dollars devoted to US manufacturing, the French drugmaker said in a statement Wednesday. The company didn’t say how much of that will represent new investments versus previous commitments.
Earlier this week Trump signed an executive order to reference drug prices in the US to lower prices paid in other countries. ...
